South-Eastern Asia: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in South-Eastern Asia

The Southeast Asian medicaments containing hormones market expanded remarkably to $X in 2023, rising by X% against the previous year. The total consumption indicated measured growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption decreased by X% against 2021 indices. The level of consumption peaked at $X in 2021; however, from 2022 to 2023, consumption failed to regain momentum.

Medicaments Containing Hormones Production in South-Eastern Asia

In value terms, medicaments containing hormones production expanded remarkably to $X in 2023 estimated in export price. The total production indicated notable growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production decreased by X% against 2021 indices. The pace of growth appeared the most rapid in 2015 when the production volume increased by X%. Over the period under review, production attained the maximum level at $X in 2021; however, from 2022 to 2023, production remained at a lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Medicaments Containing Hormones Exports

Exports in South-Eastern Asia

Medicaments containing hormones exports expanded modestly to X tons in 2023, with an increase of X% on 2022. In general, exports saw a significant increase. The pace of growth appeared the most rapid in 2014 when exports increased by X% against the previous year. Over the period under review, the exports attained the maximum at X tons in 2021; however, from 2022 to 2023, the exports stood at a somewhat lower figure.

In value terms, medicaments containing hormones exports rose to $X in 2023. Over the period under review, exports recorded strong growth. The growth pace was the most rapid in 2015 with an increase of X% against the previous year. Over the period under review, the exports attained the maximum at $X in 2021; however, from 2022 to 2023, the exports stood at a somewhat lower figure.

Exports by Country

In 2023, Indonesia (X tons) represented the main exporter of medicaments containing hormones but not antibiotics in South-Eastern Asia, comprising X% of total export.

Indonesia was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics exports, with a CAGR of X% from 2012 to 2023. While the share of Indonesia (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Indonesia ($X) also remains the largest medicaments containing hormones supplier in South-Eastern Asia.

In Indonesia, medicaments containing hormones exports expanded at an average annual rate of X% over the period from 2012-2023.

Export Prices by Country

The export price in South-Eastern Asia stood at $X per ton in 2023, leveling off at the previous year. Overall, the export price, however, recorded a abrupt decline. The most prominent rate of growth was recorded in 2013 an increase of X% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2014 to 2023, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for Indonesia.

From 2012 to 2023, the rate of growth in terms of prices for Indonesia amounted to X% per year.

Medicaments Containing Hormones Imports

Imports in South-Eastern Asia

In 2023, the amount of medicaments containing hormones but not antibiotics imported in South-Eastern Asia fell remarkably to X tons, with a decrease of X% compared with 2022 figures. Overall, imports recorded a deep reduction. The pace of growth was the most pronounced in 2013 when imports increased by X%. The volume of import peaked at X tons in 2014; however, from 2015 to 2023, imports remained at a lower figure.

In value terms, medicaments containing hormones imports reduced markedly to $X in 2023. In general, imports continue to indicate a abrupt curtailment. The pace of growth appeared the most rapid in 2017 when imports increased by X%. Over the period under review, imports attained the peak figure at $X in 2012; however, from 2013 to 2023, imports stood at a somewhat lower figure.

Imports by Country

Malaysia prevails in imports structure, resulting at X tons, which was approx. X% of total imports in 2023. Singapore (X tons) held the second position in the ranking, followed by Myanmar (X tons) and Indonesia (X tons). All these countries together held approx. X% share of total imports. Cambodia (X tons) and the Philippines (X tons) held a little share of total imports.

From 2012 to 2023, average annual rates of growth with regard to medicaments containing hormones imports into Malaysia stood at X%. At the same time, Singapore (X%) and Cambodia (X%) displayed positive paces of growth. Moreover, Singapore emerged as the fastest-growing importer imported in South-Eastern Asia, with a CAGR of X% from 2012-2023. The Philippines experienced a relatively flat trend pattern. By contrast, Myanmar (X%) and Indonesia (X%) illustrated a downward trend over the same period. Singapore (X p.p.) and Cambodia (X p.p.) significantly strengthened its position in terms of the total imports, while Indonesia and Malaysia saw its share reduced by X% and X% from 2012 to 2023, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Malaysia ($X) constitutes the largest market for imported medicaments containing hormones but not antibiotics in South-Eastern Asia, comprising X% of total imports. The second position in the ranking was taken by Singapore ($X), with an X% share of total imports. It was followed by Indonesia, with a X% share.

In Malaysia, medicaments containing hormones imports shrank by an average annual rate of X% over the period from 2012-2023. In the other countries, the average annual rates were as follows: Singapore (X% per year) and Indonesia (X% per year).

Import Prices by Country

In 2023, the import price in South-Eastern Asia amounted to $X per ton, which is down by X% against the previous year. In general, the import price recorded a abrupt contraction. The most prominent rate of growth was recorded in 2020 when the import price increased by X% against the previous year. The level of import peaked at $X per ton in 2012; however, from 2013 to 2023, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was Singapore ($X per ton), while Cambodia ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Myanmar (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform